A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate
NCT ID: NCT03014336
Last Updated: 2022-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
450 participants
INTERVENTIONAL
2017-01-31
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decreasing Environmental Impact and Costs of Using Inhalational Anesthetic With a Carbon Dioxide Membrane Filter System
NCT04210570
Evaluation of the Sevoflurane Consumption During General Anesthesia When Using the MemsorbTM Membrane
NCT04539405
The Influence of Two Different CO2 Absorbers on Sevoflurane Consumption During Anaesthesia
NCT04271462
Sustainable Anaesthesia Practices in EUROPE - a Prospective International Cohort Study
NCT07252973
Does Precise Delivery of Remifentanil Decrease Coughing at Emergence From Anesthesia
NCT03783676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
memsorb uses patented advanced medical membrane technology to filter CO2 from anesthetic circuits rather than absorbing via a chemical reaction.
This game changing technology relies on a polymeric membrane core (similar to the ones used in oxygenators for cardiac surgery) that selectively allows CO2 to leave the rebreathing system, while maintaining the anesthetic vapor in the circuit.
memsorb is a cartridge similar in size and shape to current solutions that simply clicks in place.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients receive standard care with a standard CO2 absorber and agree to include their data in the study.
No interventions assigned to this group
memsorb
Patients agree to receive standard care but using memsorb, the new CO2 filter evaluated in this study.
memsorb
memsorb is a CO2 filter replacing current chemical CO2 absorbers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
memsorb
memsorb is a CO2 filter replacing current chemical CO2 absorbers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking patients
Exclusion Criteria
* American Society of Anesthesiologists Physical Status Class IV (high risk patient)
* Patients scheduled for emergency surgery
* Documented respiratory disease, including COPD and severe asthma
* Documented elevated pressure in the brain (intra cranial pressure, ICP)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DMF Medical Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Orlando Hung, MD
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth II HSC, Halifax Infirmary Site
Halifax, Nova Scotia, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMF-CLIN-16-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.